21 results
F-1/A
ENLV
Enlivex Therapeutics Ltd
8 Jul 14
Registration statement (foreign) (amended)
12:00am
urea cycle disorders — a group of rare genetic diseases characterized by body’s inability to detoxify ammonia. Ammonia is a toxic breakdown product … to detoxify ammonia. Ammonia is a toxic breakdown product of proteins. OTCD is caused by a mutated and ineffective form of the enzyme, ornithine
20-F
2014 FY
ENLV
Enlivex Therapeutics Ltd
31 Mar 15
Annual report (foreign)
12:00am
inability to detoxify ammonia. Ammonia is a toxic breakdown product of proteins. OTCD is caused by a mutated and ineffective form of the enzyme … , ornithine transcarbamylase, that is part of the urea cycle complex in the mitochondria. As a result, the normal breakdown of ammonia is disrupted and toxic
424B4
ENLV
Enlivex Therapeutics Ltd
31 Jul 14
Prospectus supplement with pricing info
12:00am
among urea cycle disorders — a group of rare genetic diseases characterized by body’s inability to detoxify ammonia. Ammonia is a toxic breakdown … disorder among urea cycle disorders — a group of rare genetic diseases characterized by body’s inability to detoxify ammonia. Ammonia is a toxic
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
5 Mar 20
Report of Foreign Private Issuer
8:16am
, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating
6-K
EX-10.1
aglrmn2z2lr
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
nnqfqt34mkan80
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-10.1
8ubtk
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
tdhg8aizinfy3j
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-1.1
v9zsdbhdv2wa
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-99.2
i2dmfx74re3 y6pzhx4v
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F/A
fxhvv0466
23 Jan 20
Annual report (foreign) (amended)
4:31pm